Co-administration of pimavanserin with other agents

Details for Australian Patent Application No. 2008302079 (hide)

Owner Acadia Pharmaceuticals, Inc.

Inventors Hacksell, Uli; Mcfarland, Krista

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008302079

PCT Pub. Number WO2009/039460

Priority 60/974,426 21.09.07 US; 61/050,976 06.05.08 US; 60/986,250 07.11.07 US

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/039460 Priority application(s): WO2009/039460

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302086-Nanocomposite membranes and methods of making and using same

2008302076-Identification of novel pathways for drug development for lung disease